We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sandoz Requests Calif. Court Make Final Ruling in Amgen SCOTUS Case
Sandoz Requests Calif. Court Make Final Ruling in Amgen SCOTUS Case
Following the U.S. Supreme Court’s defining decision on the biosimilar “patent dance” and approval process, Sandoz has requested that an unresolved part of its case against Amgen return to a California federal district court.